Drug reference
Hypertension ▶BY MOUTH ▶Adult 18–74 years: Initially 40 mg once daily, increased if necessary to 80 mg once daily ▶Adult 75 years and over: Initially 20–40 mg once daily, increased if necessary to 80 mg once daily Hypertension with intravascular volume depletion ▶BY MOUTH ▶Adult: Initially 20–40 mg daily, increased if necessary to 80 mg daily
PDF page 208
Heart failure
PDF page 208
→Appendix 1: angiotensin-II receptor antagonists
PDF page 208
▶Uncommon Hyperuricaemia. muscle spasms. peripheral oedema
PDF page 208
Dose adjustments Manufacturer advises consider initial dose of 20 mg in mild to moderate impairment. Monitoring Manufacturer advises monitor closely in mild to moderate hepatic impairment (limited information available).
PDF page 208
Manufacturer advises caution in severe impairment—no information available.
PDF page 208
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Edarbi (Takeda UK Ltd) Azilsartan medoxomil 20 mg Edarbi 20mg tablets | 28 tablet P £16.80 DT = £16.80 Azilsartan medoxomil 40 mg Edarbi 40mg tablets | 28 tablet P £16.80 DT = £16.80 Azilsartan medoxomil 80 mg Edarbi 80mg tablets | 28 tablet P £19.95 DT = £19.95 eiiii F 185
PDF page 208
Initially 40 mg once daily, increased
First-line fragment. Read the complete Indications and Dose section above.
PDF page 208
Initially 20–40 mg once daily,
First-line fragment. Read the complete Indications and Dose section above.
PDF page 208
Initially 20–40 mg daily, increased if necessary
First-line fragment. Read the complete Indications and Dose section above.
PDF page 208
